CVS Group (LON:CVSG) Stock Price Crosses Below 200-Day Moving Average - What's Next?

Key Points

• CVS Group shares fell below their 200-day moving average, trading as low as GBX 1,137 and last at GBX 1,140, down 1.7% with 493,341 shares traded.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of GBX 1,666.67, well above the current share price.
• The company reported quarterly EPS of GBX 85.60, while insiders bought 3,860 shares over the past 90 days, signaling some internal confidence despite the stock’s recent weakness.

CVS Group plc (LON:CVSG - Get Free Report)'s share price passed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of GBX 1,227.29 and traded as low as GBX 1,137. CVS Group shares last traded at GBX 1,140, with a volume of 493,341 shares traded.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on CVSG shares. Berenberg Bank reissued a "buy" rating and set a GBX 2,000 price objective on shares of CVS Group in a research note on Thursday, September 24th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a GBX 1,700 target price on shares of CVS Group in a research note on Monday, July 27th. Shore Capital Group reiterated a "hold" rating and set a GBX 1,400 price target on shares of CVS Group in a report on Thursday, September 24th. Finally, Jefferies Financial Group reissued a "hold" rating and set a GBX 1,400 price target on shares of CVS Group in a research report on Friday, September 25th. Four investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of GBX 1,666.67.

CVS Group Trading Down 1.7%

The company has a 50 day moving average price of GBX 1,280.88 and a 200 day moving average price of GBX 1,227.29. The firm has a market cap of £774.86 million, a price-to-earnings ratio of 16.55, a price-to-earnings-growth ratio of 1.77 and a beta of 1.07. The company has a debt-to-equity ratio of 110.41, a quick ratio of 0.90 and a current ratio of 1.18.

CVS Group (LON:CVSG - Get Free Report) last issued its quarterly earnings data on Thursday, September 24th. The company reported GBX 85.60 earnings per share (EPS) for the quarter. CVS Group had a return on equity of 5.91% and a net margin of 2.43%. On average, research analysts expect that CVS Group plc will post 93.9393939 earnings per share for the current year.

Insiders Place Their Bets

In related news, insider David Wilton bought 1,500 shares of the stock in a transaction on Tuesday, August 4th. The stock was bought at an average price of GBX 1,276 per share, with a total value of £19,140. Also, insider Robin Alfonso purchased 768 shares of the company's stock in a transaction on Thursday, August 6th. The shares were bought at an average price of GBX 1,294 per share, with a total value of £9,937.92. Insiders purchased a total of 3,860 shares of company stock valued at $4,956,696 over the last 90 days. 1.48% of the stock is owned by company insiders.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy. The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct"). The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.